WHWK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Whitehawk Therapeutics Inc (WHWK) is not a strong buy for a beginner investor with a long-term horizon at this time. While the company has potential in the antibody-drug conjugates (ADC) space and hedge funds are showing interest, the lack of revenue, negative earnings, and absence of recent news or significant catalysts make it a speculative play. The technical indicators are mildly positive, but the pre-market price drop and lack of proprietary trading signals suggest caution.
The MACD is positive and expanding, indicating a bullish momentum. The RSI is neutral at 72.395, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are Pivot: 3.059, R1: 3.242, S1: 2.876, R2: 3.356, S2: 2.762. However, the pre-market price drop of -4.31% suggests caution.
Hedge funds are significantly increasing their positions, with a 230.74% buying increase over the last quarter.
Analysts have initiated coverage with positive ratings and price targets of $6 and $7, citing potential in the ADC space.
Bullish technical indicators with positive MACD and moving averages.
Pre-market price drop of -4.31%.
No revenue in the latest quarter (Q3 2025), with a YoY drop of -100%.
EPS dropped to -0.26, down -43.48% YoY.
No recent news or significant catalysts.
No proprietary trading signals from AI Stock Picker or SwingMax.
In Q3 2025, revenue dropped to 0 (-100% YoY). Net income improved to -$17,746,000 (up 41.45% YoY), but EPS dropped to -0.26 (-43.48% YoY). Gross margin increased slightly to 89.36% (+0.57% YoY). Overall, the financials indicate a lack of revenue and profitability.
Analysts from Oppenheimer and JonesResearch initiated coverage with Outperform/Buy ratings and price targets of $6 and $7, respectively. They view Whitehawk as a promising player in the ADC space, with potential for best-in-class designation. However, clinical trials are still in early stages, and significant milestones are expected in 2026.
